Your Article Summary
Human genome sciences announces new order for raxibacumab (abthrax) from u.s. government
Human Genome Sciences, 07/23/09
Human Genome Sciences, Inc. announced that the U.S. Government has exercised its option to purchase an additional 45,000 doses of raxibacumab (ABthrax) for the Strategic National Stockpile, to be delivered over a three–year period, beginning near the end of 2009. HGS expects to receive approximately $151 million from this award as deliveries are completed.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor


See Latest Articles


